Prospective Association of Dopamine-Related Polymorphisms with Smoking Cessation in General Care

• Lerman C , PattersonF, BerrettiniW: Treating tobacco dependence: state of the science and new directions.J. Clin. Oncol.23(2) , 311–323 (2005).
   PubMed Web of Science ®Google Scholar
• Hughes JR , SteadLF, LancasterT: Antidepressants for smoking cessation.Cochrane Database Syst. Rev.(1) , CD000031 (2007).
   Google Scholar
• Batra V , PatkarAA, BerrettiniWH, WeinsteinSP, LeoneFT: The genetic determinants of smoking.Chest123(5) , 1730–1739 (2003).
   PubMed Web of Science ®Google Scholar
• Li MD : Identifying susceptibility loci for nicotine dependence: 2008 update based on recent genome-wide linkage analyses.Hum. Genet.123(2) , 119–131 (2008).
   PubMed Web of Science ®Google Scholar
• Ho MK , TyndaleRF: Overview of the pharmacogenomics of cigarette smoking.Pharmacogenomics J.7(2) , 81–98 (2007).
   PubMed Web of Science ®Google Scholar
• Munafo MR , ShieldsAE, BerrettiniWH, PattersonF, LermanC: Pharmacogenetics and nicotine addiction treatment.Pharmacogenomics6(3) , 211–223 (2005).
   PubMed Web of Science ®Google Scholar
• Lerman CE , SchnollRA, MunafoMR: Genetics and smoking cessation improving outcomes in smokers at risk.Am. J. Prev. Med.33(Suppl. 6) , S398–S3405 (2007).
   PubMed Web of Science ®Google Scholar
• Johnstone EC , YudkinPL, HeyK et al.: Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch.Pharmacogenetics14(2) , 83–90 (2004).
   PubMedGoogle Scholar
• Twardella D , BrennerH: Effects of practitioner education, practitioner payment and reimbursement of patients‘ drug costs on smoking cessation in primary care: a cluster randomised trial.Tob. Control16(1) , 15–21 (2007).
   PubMed Web of Science ®Google Scholar
• Twardella D , BrennerH: Lack of training as a central barrier to the promotion of smoking cessation: a survey among general practitioners in Germany.Eur. J. Public Health15(2) , 140–145 (2005).
   PubMed Web of Science ®Google Scholar
• Heatherton TF , KozlowskiLT, FreckerRC, FagerstromKO: The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire.Br. J. Addict.86(9) , 1119–1127 (1991).
   PubMedGoogle Scholar
• DiClemente CC , ProchaskaJO, FairhurstSK, VelicerWF, VelasquezMM, RossiJS: The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change.J. Consult. Clin. Psychol.59(2) , 295–304 (1991).
   PubMed Web of Science ®Google Scholar
• SRNT Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob. Res.4(2) , 149–159 (2002).
   PubMedGoogle Scholar
• Hughes JR , KeelyJP, NiauraRS, Ossip-KleinDJ, RichmondRL, SwanGE: Measures of abstinence in clinical trials: issues and recommendations.Nicotine Tob. Res.5(1) , 13–25 (2003).
   PubMed Web of Science ®Google Scholar
• Savitz DA , OlshanAF: Multiple comparisons and related issues in the interpretation of epidemiologic data.Am. J. Epidemiol.142(9) , 904–908 (1995).
   PubMed Web of Science ®Google Scholar
• SAS Institute: Statistical analysis software, release 9.2. SAS Institute: NC, USA (2008).
   Google Scholar
• Rothman KJ , GreenlandS, LashTL: Modern Epidemiology. 3rd Edition. Lippincott Williams & Wilkins, PA, USA, 758 (2008).
   Google Scholar
• Cinciripini P , WetterD, TomlinsonG et al.: The effects of the DRD2 polymorphism on smoking cessation and negative affect: evidence for a pharmacogenetic effect on mood.Nicotine Tob. Res.6(2) , 229–239 (2004).
   PubMed Web of Science ®Google Scholar
• Berlin I , CoveyLS, JiangH, HamerD: Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation.Nicotine Tob. Res.7(5) , 725–728 (2005).
   PubMed Web of Science ®Google Scholar
• Robinson JD , LamCY, MinnixJA et al.: The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms.Pharmacogenomics J.7(4) , 266–274 (2007).
   PubMed Web of Science ®Google Scholar
• Yudkin P , MunafoM, HeyK et al.: Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.BMJ328(7446) , 989–990 (2004).
   PubMedGoogle Scholar
• Swan GE , JackLM, ValdesAM et al.: Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.Health Psychol.26(3) , 361–368 (2007).
   PubMed Web of Science ®Google Scholar
• Lerman C , ShieldsPG, WileytoEP et al.: Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial.Health Psychol.22(5) , 541–548 (2003).
   PubMed Web of Science ®Google Scholar
• David SP , BrownRA, PapandonatosGD et al.: Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.Nicotine Tob. Res.9(8) , 821–833 (2007).
   PubMed Web of Science ®Google Scholar
• Ton TG , RossingMA, BowenDJ, SrinouanprachanS, WicklundK, FarinFM: Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study.Behav. Brain Funct.3 , 22 (2007).
   PubMed Web of Science ®Google Scholar
• Swan GE , ValdesAM, RingHZ et al.: Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR.Pharmacogenomics J.5(1) , 21–29 (2005).
   PubMed Web of Science ®Google Scholar
• Munafo M , ClarkT, JohnstoneE, MurphyM, WaltonR: The genetic basis for smoking behavior: a systematic review and meta-analysis.Nicotine Tob. Res.6(4) , 583–597 (2004).
   PubMed Web of Science ®Google Scholar
• Huang W , PayneTJ, MaJZ et al.: Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African–American sample.Neuropsychopharmacology34(2) , 319–330 (2009).
   PubMed Web of Science ®Google Scholar
• Dick DM , WangJC, PlunkettJ et al.: Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1.Alcohol. Clin. Exp. Res.31(10) , 1645–1653 (2007).
   PubMed Web of Science ®Google Scholar
• Gelernter J , YuY, WeissR et al.: Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations.Hum. Mol. Genet.15(24) , 3498–3507 (2006).
   PubMed Web of Science ®Google Scholar
• David SP , NiauraR, PapandonatosGD et al.: Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?Nicotine Tob. Res.5(6) , 935–942 (2003).
   PubMed Web of Science ®Google Scholar
• Lerman C , JepsonC, WileytoEP et al.: Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.Neuropsychopharmacology31(1) , 231–242 (2006).
   PubMed Web of Science ®Google Scholar
• Salanti G , AmountzaG, NtzaniEE, IoannidisJP: Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power.Eur. J. Hum. Genet.13(7) , 840–848 (2005).
   PubMed Web of Science ®Google Scholar
• Styn MA , NukuiT, RomkesM, PerkinsK, LandSR, WeissfeldJL: The impact of genetic variation in DRD2 and SLC6A3 on smoking cessation in a cohort of participants 1 year after enrollment in a lung cancer screening study.Am. J. Med. Genet. B Neuropsychiatr. Genet.150B(2) , 254–261 (2009).
   PubMed Web of Science ®Google Scholar
• Comings DE , MacMurrayJP: Molecular heterosis: a review.Mol. Genet. Metab.71(1–2) , 19–31 (2000).
   PubMed Web of Science ®Google Scholar
• Comings DE : Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density.Mol. Psychiatry4(3) , 213–215 (1999).
   PubMed Web of Science ®Google Scholar
• Lee HS : Gender-specific molecular heterosis and association studies: dopamine D2 receptor gene and smoking.Am. J. Med. Genet. B Neuropsychiatr. Genet.118B(1) , 55–59 (2003).
   PubMed Web of Science ®Google Scholar
• Lee HS , KimSH, LeeHJ et al.: Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia.Am. J. Med. Genet.114(6) , 593–597 (2002).
   PubMed Web of Science ®Google Scholar
• Agrawal A , HeathAC, GrantJD et al.: Assortative mating for cigarette smoking and for alcohol consumption in female Australian twins and their spouses.Behav. Genet.36(4) , 553–566 (2006).
   PubMed Web of Science ®Google Scholar
• Cubells J : Genetic research on nicotine dependence will facilitate public health.PLoS Med.2(11) , E396 (2005).
   PubMed Web of Science ®Google Scholar
• Hall WD : Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?PLoS Med.2(9) , E266 (2005).
   PubMed Web of Science ®Google Scholar

▪ Websites

• Invitek. www.invitek.eu
   Google Scholar
• Hapmap data release Rel 21a/phaseII January (2007). http://hapmap.ncbi.nlm.nih.gov/downloads/genotypes/2007-01
   Google Scholar